Data as of Jan 29
| +0.0019 / +0.14%|
Dynasil Corp. of America develops, manufactures, and markets detection, sensing, and analysis technology products for the homeland security, medical and industrial markets. It operates through four segments: Contract Research, Optics, Instruments and Biomedical. The Contract Research segment consists of the Radiation Monitoring Devices, Inc. which performs research and development activities for government agencies. The Optics segment supplies synthetic crystals, optical materials, components, and coatings that are used for baggage scanners, medical imaging systems, optical instruments, lasers, analytical instruments, semiconductor/electronic devices, automotive components, spacecraft/aircraft components, advertising displays, and devices for the solar energy industry. These products are offered through four business units: Dynasil Fused Silica, Optometrics, Hilger Crystal, and Evaporated Metal Films. The Instruments segment manufactures precision instruments such as handheld lead paint analyzers, medical probes that help surgeons detect cancer tracers, thereby enabling more effective surgical procedures, and a radiation imaging camera system used in nuclear safety, radiation protection, and homeland security border and port surveillance. The Biomedical segment focuses on developing disruptive technologies for a wide spectrum of applications, including hematology, hypothermic core cooling and tissue sealants. This segment consists of single business unit, Dynasil Biomedical corp. a medical technology incubator. Dynasil Corp. of America was founded in October 20, 1960 and is headquartered in Watertown, MA.
|Peter Sulick||Chairman, President & Chief Executive Officer|
|Thomas C. Leonard||Chief Financial Officer|
|Bruce M. Leonetti||Vice President-Optical Material Sales|
|Patricia M. Kehe||Secretary & Head-Investor Relations|